Rapid-acting insulin

This page covers all Rapid-acting insulin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (4)

• Inhaled insulin (Exubera) · Pfizer · Diabetes
  Inhaled insulin is a rapid-acting insulin that is absorbed through the lungs to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.
• Afrezza plus One Drop | Premium · Informed Data Systems, Inc. · Diabetes
  Afrezza is a rapid-acting inhaled insulin that delivers insulin directly to the lungs for quick absorption into the bloodstream to lower blood glucose.
• Insulin Actrapid · University of Nottingham · Diabetes
  Insulin Actrapid is a rapid-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
• soluble human insulin · Novo Nordisk A/S · Diabetes
  Soluble human insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.

Phase 3 pipeline (3)

• Insulin VIAject™ (90%) · Biodel · Diabetes
  Insulin VIAject is a rapid-acting insulin formulation designed to achieve faster absorption and onset of action compared to standard insulin injections.
• VIAject™ · Biodel · Diabetes
  VIAject is a rapid-acting insulin formulation that uses a proprietary excipient system to accelerate insulin absorption and onset of action.
• Insulin VIAject™ (75%) · Biodel · Diabetes
  Insulin VIAject is a rapid-acting insulin formulation designed to be absorbed faster than standard insulin injections, allowing for quicker onset of action and better postprandial glucose control.

Phase 2 pipeline (1)

• BIOD-123 · Biodel · Diabetes
  BIOD-123 is a rapid-acting insulin formulation designed to improve postprandial glucose control in diabetes patients.